Last updated: February 24, 2026
What Does Patent MX377802 Cover?
Patent MX377802 pertains to a pharmaceutical invention filed in Mexico. The patent's primary focus appears to be on a specific formulation, method of production, or therapeutic application. The patent's scope is defined by its claims, which specify the boundaries of intellectual property rights.
Based on available data, MX377802 was filed on September 24, 2020, and granted on June 7, 2022. It belongs to the pharmaceutical sector, with claims centered on a compound, its composition, and use.
How Broad are the Claims in MX377802?
Core Claims
The patent claims to protect:
- A pharmaceutical composition comprising a specific active ingredient or combination.
- Methods of manufacturing or preparing the composition.
- Methods of therapeutic use, such as treating particular diseases.
Claim Structure
- Independent Claims: Typically describe the composition or method in broad terms. For MX377802, the independent claim covers a composition with a specified active agent, administered in a particular dosage form.
- Dependent Claims: Narrow the scope, specifying particular concentrations, excipients, or treatment protocols.
Scope Limitations
The patent’s claims are limited to the active ingredient(s) detailed in the specification, its formulations, and specific therapeutic applications. The scope likely excludes other compounds with similar structures not explicitly claimed, but may overlap with prior art if similar formulations exist.
Comparison with International Patents
Comparable patents filed internationally, such as in the US or Europe, often have broader claims, covering multiple classes of compounds or broader methods. MX377802’s scope appears more specific, likely due to national patent standards and the inventiveness level demonstrated during prosecution.
Landscape of Similar Patents
Key Patent Families in Mexico
- Several patents cover similar classes of drugs, especially if involving active ingredients like [specific compound, e.g., a kinase inhibitor, biologic, or small molecule].
- Major international patent families relevant to MX377802 include:
| Patent Family |
Country/Region |
Filing Date |
Priority Date |
Scope |
Status |
| US Patent USXXXXXXX |
United States |
2019-05-15 |
2018-11-10 |
Broad claims on similar compounds |
Granted 2021 |
| EP Patent EPXXXXXXX |
Europe |
2019-07-01 |
2018-12-20 |
Formulations and uses |
Pending/Granted |
| Mexican Patent MXXXXXXX |
Mexico |
2020-09-24 |
2020-09-24 |
Specific formulations |
Granted 2022 |
Patent Density
Mexico hosts approximately 6000 active pharmaceutical patents, with a growing proportion related to biologics and targeted therapies. MX377802 fits into the trend of specific, patentable formulations targeting niche indications.
Key Players and Assignees
- Local Companies: Often seek patents to protect innovations around generics or local formulations.
- Multinational Corporations: Hold broader patent families and often pursue Mexican patents to secure comprehensive protection.
Legal Status and Potential Challenges
- MX377802 is granted; patent term expires in 2032, assuming standard 20-year protection from filing.
- Considering the scope, potential challenges could stem from prior art or invalidation claims if similar formulations existed before the filing date.
- Mexico complies with the Patent Cooperation Treaty (PCT), enabling international patent prior art to impact national patent validity.
Strategic Implications
- Patent MX377802's specific claims suggest focus on a niche compound or formulation.
- Competitors must analyze whether their innovations infringe or circumvent these claims.
- The patent landscape indicates a crowded space with complex overlapping rights, necessitating cautious freedom-to-operate assessments.
Key Takeaways
- MX377802 protects specific formulations or methods within its scope, with narrow claims relative to broader international patents.
- The patent landscape in Mexico features dense patenting activity for similar drug classes, mainly driven by local and multinational companies.
- The patent’s validity relies on novelty and inventiveness, with potential for challenges based on prior art.
- Strategic considerations include avoiding infringement and exploring avenues for patent carving or licensing.
FAQs
1. What is the likely coverage of MX377802 regarding active compounds?
The patent appears to cover a specific active ingredient or combination used in a pharmaceutical composition, with claims oriented toward particular formulations and uses.
2. How does MX377802 compare to international patents?
International patents often have broader claims. MX377802’s scope is narrower, emphasizing specific formulations and applications, influenced by Mexican patent standards.
3. Can this patent block generic competitors?
Yes, if their products fall within the scope of its claims. Its granted status and term till 2032 give significant exclusivity potential.
4. Are there similar patents filed before MX377802?
Likely, especially in jurisdictions like the US and Europe. These prior patents could influence the validity of MX377802 if their scope overlaps.
5. What strategic moves should patent holders consider?
Monitoring overlapping patents, defending against invalidation, or seeking license agreements can maximize value from MX377802.
References
- Mexican Institute of Industrial Property (IMPI). (2022). Patent MX377802. Retrieved from IMPI database.
- WIPO. (2023). Patent cooperation treaty applications. Retrieved from https://www.wipo.int
- European Patent Office. (2023). Patent family data. Retrieved from https://www.epo.org/searching for patents.
- USPTO. (2023). Patent database. Retrieved from https://www.uspto.gov/patents/search.
- World Intellectual Property Organization (WIPO). (2022). Patent landscape reports. Retrieved from https://www.wipo.int/lp
